Progression of KRAS mutant pancreatic adenocarcinoma during vemurafenib treatment in a patient with metastatic melanoma

A. Grey, A. Cooper, C. Mcneil, Sandra O'Toole, J. Thompson, P. Grimison

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Progression of KRAS mutant pancreatic adenocarcinoma during vemurafenib treatment in a patient with metastatic melanoma'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science